135 related articles for article (PubMed ID: 6171547)
1. Clinical pharmacology of bleomycin and cisplatin.
Evans WE; Yee GC; Crom WR; Pratt CB; Green AA
Head Neck Surg; 1981; 4(2):98-110. PubMed ID: 6171547
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of bleomycin and cisplatin.
Evans WE; Yee GC; Crom WR; Pratt CB; Green AA
Drug Intell Clin Pharm; 1982 Jun; 16(6):448-58. PubMed ID: 6178575
[TBL] [Abstract][Full Text] [Related]
3. Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure.
Bennett WM; Pastore L; Houghton DC
Cancer Treat Rep; 1980; 64(8-9):921-4. PubMed ID: 6160913
[TBL] [Abstract][Full Text] [Related]
4. Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.
Haines I; Bosl G; Pfister D; Spiro R; Gerold F; Sessions R; Shah J; Strong E; Vikram B; Harrison L
J Clin Oncol; 1987 Oct; 5(10):1594-600. PubMed ID: 2443621
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
Kelsen D; Hilaris B; Coonley C; Chapman R; Lesser M; Dukeman M; Heelan R; Bains M
Am J Med; 1983 Oct; 75(4):645-52. PubMed ID: 6194685
[TBL] [Abstract][Full Text] [Related]
6. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706
[TBL] [Abstract][Full Text] [Related]
7. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
Wheeler RH; Baker SR; Liepman MK; Ensminger WD
Med Pediatr Oncol; 1983; 11(1):12-9. PubMed ID: 6188032
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-induced changes in bleomycin elimination.
Yee GC; Crom WR; Champion JE; Brodeur GM; Evans WE
Cancer Treat Rep; 1983 Jun; 67(6):587-9. PubMed ID: 6190560
[TBL] [Abstract][Full Text] [Related]
9. Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients.
van der Schoot GGF; Westerink NL; Lubberts S; Nuver J; Zwart N; Walenkamp AME; Wempe JB; Meijer C; Gietema JA
Eur J Cancer; 2016 May; 59():134-141. PubMed ID: 27033261
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy.
Randolph VL; Vallejo A; Spiro RH; Shah J; Strong EW; Huvos AG; Wittes RE
Cancer; 1978 Feb; 41(2):460-7. PubMed ID: 75760
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
[TBL] [Abstract][Full Text] [Related]
12. The effects of prior exposure to bleomycin on the incidence of pulmonary toxicities in a group of patients with disseminated testicular carcinomas.
Crooke ST; Einhorn LH; Comis RL; D'Aoust JC; Prestayko AW
Med Pediatr Oncol; 1978; 5(1):93-8. PubMed ID: 85253
[TBL] [Abstract][Full Text] [Related]
13. Toxicity comparisons between two chemotherapy regimens as adjuvant or salvage treatment in nonseminomatous testicular cancer.
Weiss RB; Stablein DM; Muggia FM; Einhorn LH; Golbey RB; DeWys WD
Cancer; 1988 Jul; 62(1):18-23. PubMed ID: 2454718
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion.
Hong WK; Shapshay SM; Bhutani R; Craft ML; Ucmakli A; Yamaguchi KT; Vaughan CW; Strong MS
Cancer; 1979 Jul; 44(1):19-25. PubMed ID: 88255
[TBL] [Abstract][Full Text] [Related]
15. Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck.
Posner MR; Weichselbaum RR; Fitzgerald TJ; Clark JR; Rose C; Fabian RL; Norris CM; Miller D; Tuttle SA; Ervin TJ
Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1887-93. PubMed ID: 2414254
[TBL] [Abstract][Full Text] [Related]
16. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
[TBL] [Abstract][Full Text] [Related]
17. Serum creatinine level during chemotherapy for testicular cancer as a possible predictor of bleomycin-induced pulmonary toxicity.
Kawai K; Hinotsu S; Tomobe M; Akaza H
Jpn J Clin Oncol; 1998 Sep; 28(9):546-50. PubMed ID: 9793027
[TBL] [Abstract][Full Text] [Related]
18. Bleomycin: its utilization in the treatment of head and neck cancer.
Bone RC; Byfield JE; Feren AP; Seagren SL
Laryngoscope; 1979 Feb; 89(2 Pt 1):224-33. PubMed ID: 85232
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors.
Haugnes HS; Oldenburg J; Bremnes RM
Urol Oncol; 2015 Sep; 33(9):399-406. PubMed ID: 25554583
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
Kelsen DP; Bains M; Hilaris B; Chapman R; McCormack P; Alexander J; Hopfan S; Martini N
Cancer; 1982 Mar; 49(6):1174-7. PubMed ID: 6174199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
